A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer.
Canney, Peter A
Wilkinson, Peter M
AffiliationRoyal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London W12 0HS
MetadataShow full item record
AbstractA new method with a low pH step to dissociate serum complexes has been developed to measure serum levels of antigens associated with ovarian cancer. The antigens are detected by monoclonal antibodies HMFG1 and HMFG2 and have been compared to an existing ovarian cancer associated antigen detected by the antibody CA125. Elevated HMFG1 was found in 56%, and elevated HMFG2 in 65% of 924 sera from 85 patients with ovarian cancer. CA125 was elevated in 85% of these sera. When the three markers were used in conjunction, 95% of sera from patients with ovarian cancer were positive--compared with 7% in sera from healthy control subjects. Therefore, the combination of HMFG1, HMFG2 and CA125 increases the diagnostic accuracy. If all three markers are normal in a patient previously treated for ovarian cancer then no further positive information regarding disease status can be obtained by ultrasound and CT scanning.
CitationA new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer. 1986, 54 (6):891-5 Br J Cancer
JournalBritish Journal of Cancer
- A low pH enzyme linked immunoassay using two monoclonal antibodies for the serological detection and monitoring of breast cancer.
- Authors: Dhokia B, Pectasides D, Self C, Habib NA, Hershman M, Wood CB, Munro AJ, Epenetos AA
- Issue date: 1986 Dec
- Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2.
- Authors: van Dam PA, Lowe DG, Watson JV, Jobling TW, Chard T, Shepherd JH
- Issue date: 1991 Jul 1
- Circulating tumor-associated antigen detected by the monoclonal antibody HMFG2 in human epithelial ovarian cancer.
- Authors: Ward BG, Cruickshank DJ
- Issue date: 1987 Jan 15
- The ovarian-carcinoma-associated sebaceous gland antigen is a member of the HMFG2-positive family of epithelial mucins.
- Authors: de Kretser T
- Issue date: 1988
- The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125.
- Authors: Fisken J, Roulston JE, Sturgeon C, Badley RA, Jönrup I, Aspinall L, Leonard RC
- Issue date: 1993 May